These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 10744006)
41. [Methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in hemodialysing patients]. Yao Y; Liu H; Zhang X; Duan X Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):522-5. PubMed ID: 12421498 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy. Vurucu S; Demirkaya E; Kul M; Unay B; Gul D; Akin R; Gokçay E Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):844-8. PubMed ID: 18234410 [TBL] [Abstract][Full Text] [Related]
43. Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease. Bhargava S; Parakh R; Manocha A; Ali A; Srivastava LM Vascular; 2007; 15(3):149-53. PubMed ID: 17573020 [TBL] [Abstract][Full Text] [Related]
44. [Homocysteinemia and ovariectomy--initial experience with functional monitoring]. Kaprál A; Hyánek J; Zivný J; Pejznochová H; Dubská L; Fait T Ceska Gynekol; 2002 Nov; 67(6):328-32. PubMed ID: 12661370 [TBL] [Abstract][Full Text] [Related]
45. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Golbahar J; Hamidi A; Aminzadeh MA; Omrani GR Bone; 2004 Sep; 35(3):760-5. PubMed ID: 15336613 [TBL] [Abstract][Full Text] [Related]
46. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. Brunelli T; Prisco D; Fedi S; Rogolino A; Farsi A; Marcucci R; Giusti B; Pratesi C; Pulli R; Gensini GF; Abbate R; Pepe G J Vasc Surg; 2000 Sep; 32(3):531-6. PubMed ID: 10957660 [TBL] [Abstract][Full Text] [Related]
47. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. Ridker PM; Stampfer MJ; Rifai N JAMA; 2001 May; 285(19):2481-5. PubMed ID: 11368701 [TBL] [Abstract][Full Text] [Related]
48. A common 844INS68 insertion variant in the cystathionine beta-synthase gene. Kluijtmans LA; Boers GH; Trijbels FJ; van Lith-Zanders HM; van den Heuvel LP; Blom HJ Biochem Mol Med; 1997 Oct; 62(1):23-5. PubMed ID: 9367794 [TBL] [Abstract][Full Text] [Related]
49. Homocysteine screening of a female Hispanic population. Wu AH; Holtman V; Tsongalis GJ; Macer J Int J Mol Med; 1999 Sep; 4(3):295-7. PubMed ID: 10425282 [TBL] [Abstract][Full Text] [Related]
50. Hyperhomocysteinemia and premature vascular occlusive disease. Guba SC; Fink LM; Fonseca V Am J Med Sci; 1998 Apr; 315(4):279-85. PubMed ID: 9537644 [TBL] [Abstract][Full Text] [Related]
51. Contribution of dietary intakes of antioxidants to homocysteine-induced low density lipoprotein (LDL) oxidation in atherosclerotic patients. Seo H; Oh H; Park H; Park M; Jang Y; Lee M Yonsei Med J; 2010 Jul; 51(4):526-33. PubMed ID: 20499417 [TBL] [Abstract][Full Text] [Related]
52. Plasma homocysteine and retinal artery occlusive disease: a case-control study. Narin F; Narin N; Halici C; Oner AO; Dogan H; Karakukcu M Ann Saudi Med; 2004; 24(3):186-8. PubMed ID: 15307456 [TBL] [Abstract][Full Text] [Related]
53. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. Taylor LM; Moneta GL; Sexton GJ; Schuff RA; Porter JM J Vasc Surg; 1999 Jan; 29(1):8-19; discussion 19-21. PubMed ID: 9925456 [TBL] [Abstract][Full Text] [Related]
54. Hyperhomocysteinemia in patients with arterial occlusive disease. Aksoy M; Basar Y; Salmayenli N; Ayalp K; Genc FA; Dilege S; Kayabali M; Baktiroglu S; Kurtoglu M Surg Today; 2006; 36(4):327-31. PubMed ID: 16554989 [TBL] [Abstract][Full Text] [Related]
55. Helicobacter pylori masks differences in homocysteine plasma levels between controls and type 2 diabetic patients. Cenerelli S; Bonazzi P; Galeazzi R; Testa I; Bonfigli AR; Sirolla C; Giunta S; Galeazzi L; Fumelli D; Testa R Eur J Clin Invest; 2002 Mar; 32(3):158-62. PubMed ID: 11895466 [TBL] [Abstract][Full Text] [Related]
56. Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile. Donner MG; Klein GK; Mathes PB; Schwandt P; Richter WO Metabolism; 1998 Mar; 47(3):273-9. PubMed ID: 9500562 [TBL] [Abstract][Full Text] [Related]
57. Relationship between homocysteine and thrombotic disease. Selhub J; D'Angelo A Am J Med Sci; 1998 Aug; 316(2):129-41. PubMed ID: 9704666 [TBL] [Abstract][Full Text] [Related]
58. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Wald DS; Law M; Morris JK BMJ; 2002 Nov; 325(7374):1202. PubMed ID: 12446535 [TBL] [Abstract][Full Text] [Related]
59. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease. Li J; Gu C; Zhu M; Li D; Chen L; Zhu X Psychogeriatrics; 2020 Mar; 20(2):180-188. PubMed ID: 31828903 [TBL] [Abstract][Full Text] [Related]
60. Role of homocysteine in age-related vascular and non-vascular diseases. Parnetti L; Bottiglieri T; Lowenthal D Aging (Milano); 1997 Aug; 9(4):241-57. PubMed ID: 9359935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]